AstraZeneca talks up US growth as China problems fester

AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business faces challenges amid a probe that has battered the drugmakers share price.

Posted by Hicham ALAOUI RIZQ on 2024, Nov 13